Cancer Spread Near Brain Disrupts Lymphatic Drainage

Cancer cells that spread to the area bordering the brain interfere with lymphatic drainage vessels, thereby hindering anti-tumour immune responses, according to an analysis published online on September 30, 2026, in Nature. The study, identified by the DOI 10.1038/d41586-026-02783-z, details how bone-eroding cancer cells can obstruct the critical lymphatic system, which plays a vital role in immune surveillance and fluid balance. This obstruction can lead to a buildup of fluid and immune cells in the surrounding tissues, creating an environment that is less conducive to fighting the cancer.

The lymphatic system is a network of vessels and nodes that circulates lymph fluid throughout the body. This fluid contains immune cells that help fight infection and disease. When cancer spreads to or near the brain, it can affect the delicate balance of this system. The research highlights that the bone-eroding properties of certain cancer cells are key to this disruption. These cells release enzymes that break down bone tissue, and in doing so, they can also damage the nearby lymphatic vessels. This damage can cause the vessels to collapse or become blocked, preventing the normal flow of lymph fluid.

This interference with lymphatic drainage has significant implications for the body's ability to mount an effective immune response against the cancer. Immune cells that would normally travel through the lymph to reach the tumour site are impeded. Furthermore, the accumulation of fluid and inflammatory molecules in the affected area can create a microenvironment that shields the cancer cells from immune attack. This can make it more difficult for the immune system to recognize and destroy the cancerous cells, potentially accelerating the progression of the disease.

The findings of this analysis are crucial for understanding the complex mechanisms by which cancer spreads and establishes itself in challenging anatomical locations. By elucidating the role of lymphatic disruption, the research opens new avenues for therapeutic interventions. Targeting the mechanisms by which cancer cells erode bone and damage lymphatic vessels could offer novel strategies to restore immune function and improve treatment outcomes for patients with cancers that have spread to the vicinity of the brain. Further research may focus on developing drugs that inhibit these bone-eroding enzymes or that help to repair or bypass the damaged lymphatic pathways, thereby enhancing the body's natural defence mechanisms against the malignancy.